# Invus' Biotech Investments: 50 Startups in Its Portfolio (2026) > The 50 Biotech startups Invus has backed, by stage: $9.0B raised between them. From the rounds we track; updated nightly. Source: https://millionrounds.com/portfolio-maps/invus-biotech-portfolio (Millionrounds; every figure on the page links to its filing or article) ## Stage not reported 16 - [Tyra Biosciences](https://millionrounds.com/company/tyra-biosciences) - [Leyden Labs](https://millionrounds.com/company/leyden-labs) - [Schrödinger](https://millionrounds.com/company/schrodinger) - [Cartesian Therapeutics](https://millionrounds.com/company/cartesian-therapeutics) - [Kaleido BioSciences](https://millionrounds.com/company/kaleido-biosciences) - [LEXEO Therapeutics](https://millionrounds.com/company/lexeo-therapeutics) - [Ablative Solutions](https://millionrounds.com/company/ablative-solutions) - [PatientsLikeMe](https://millionrounds.com/company/patientslikeme) - [ITeos Therapeutics](https://millionrounds.com/company/iteos-therapeutics) - [Bambusa Therapeutics](https://millionrounds.com/company/bambusa-therapeutics) - [*I* Imvax](https://millionrounds.com/company/imvax) - [Inotrem](https://millionrounds.com/company/inotrem) - [Ikena Oncology](https://millionrounds.com/company/ikena-oncology) - [MaaT Pharma](https://millionrounds.com/company/maat-pharma) - [Cyclerion Therapeutics](https://millionrounds.com/company/cyclerion-therapeutics) - [One Biosciences](https://millionrounds.com/company/one-biosciences) ## Series B 14 - [*B* BioNTech](https://millionrounds.com/company/biontech) - [Laronde](https://millionrounds.com/company/laronde) - [*CT* City Therapeutics](https://millionrounds.com/company/city-therapeutics) - [Matchpoint Therapeutics](https://millionrounds.com/company/matchpoint-therapeutics) - [Osanni Bio](https://millionrounds.com/company/osanni-bio) - [Repertoire Immune Medicines](https://millionrounds.com/company/repertoire-immune-medicines) - [Septerna](https://millionrounds.com/company/septerna) - [MOMA Therapeutics](https://millionrounds.com/company/moma-therapeutics) - [Achilles Therapeutics](https://millionrounds.com/company/achilles-therapeutics) - [Vigil Neuroscience](https://millionrounds.com/company/vigil-neuroscience) - [AlloVir](https://millionrounds.com/company/allovir) - [*OP* Oyster Point](https://millionrounds.com/company/oyster-point) - [Contraline](https://millionrounds.com/company/contraline) - [NextPoint Therapeutics](https://millionrounds.com/company/nextpoint-therapeutics) ## Series A 10 - [Erasca](https://millionrounds.com/company/erasca) - [Morphic Therapeutic](https://millionrounds.com/company/morphic-therapeutic) - [Averna Therapeutics](https://millionrounds.com/company/averna-therapeutics) - [Ottimo Pharma](https://millionrounds.com/company/ottimo-pharma) - [Kronos Bio](https://millionrounds.com/company/kronos-bio) - [Exsilio Therapeutics](https://millionrounds.com/company/exsilio-therapeutics) - [Faze Medicines](https://millionrounds.com/company/faze-medicines) - [Triplet Therapeutics](https://millionrounds.com/company/triplet-therapeutics) - [Coave Therapeutics](https://millionrounds.com/company/coave-therapeutics) - [*VS* Viseon Spine](https://millionrounds.com/company/viseon-spine) ## Series C and later 10 - [Arcus Biosciences](https://millionrounds.com/company/arcus-biosciences) - [Encoded Therapeutics](https://millionrounds.com/company/encoded-therapeutics) - [Solid Biosciences](https://millionrounds.com/company/solid-biosciences) - [Metacrine](https://millionrounds.com/company/metacrine) - [Rani Therapeutics](https://millionrounds.com/company/rani-therapeutics) - [Hemab](https://millionrounds.com/company/hemab) - [KSQ Therapeutics](https://millionrounds.com/company/ksq-therapeutics) - [Lyndra Therapeutics](https://millionrounds.com/company/lyndra-therapeutics) - [*SB* SQZ Biotechnologies](https://millionrounds.com/company/sqz-biotechnologies) - [Ring Therapeutics](https://millionrounds.com/company/ring-therapeutics) ## Segment by segment ### Stage not reported 16 startups · $2.2B raised - [**Tyra Biosciences**](https://millionrounds.com/company/tyra-biosciences) Tyra Biosciences is a biotechnology company targeting new pathways of acquired resistance in oncology with purpose-built drugs. United States $600M - [**Leyden Labs**](https://millionrounds.com/company/leyden-labs) Leyden Labs, founded in June 2020 in Leiden, Netherlands, is a biotechnology company focused on developing innovative solutions fo Netherlands $221M - [**Schrödinger**](https://millionrounds.com/company/schrodinger) Schrödinger is the scientific leader in developing state-of-the-art chemical simulation software for use in pharmaceutical, biotec United States $195M - [**Cartesian Therapeutics**](https://millionrounds.com/company/cartesian-therapeutics) Pioneering Potent, Safer Cell Therapy in and Beyond Oncology United States $180M - [**Kaleido BioSciences**](https://millionrounds.com/company/kaleido-biosciences) Kaleido BioSciences is a company working to design and analyze the microbiome system and provide adaptive solutions. United States $161M - [**LEXEO Therapeutics**](https://millionrounds.com/company/lexeo-therapeutics) LEXEO Therapeutics utilizes gene therapy to treat genetically defined cardiovascular and central nervous system diseases. United States $154M - [**Ablative Solutions**](https://millionrounds.com/company/ablative-solutions) Ablative Solutions is a clinical-stage medical device company founded in 2011, based in Wakefield, Massachusetts. United States $130M - [**PatientsLikeMe**](https://millionrounds.com/company/patientslikeme) PatientsLikeMe is a leading personalized health network and digital health management platform. United States $127M ### Series B 14 startups · $2.9B raised - [*B* **BioNTech**](https://millionrounds.com/company/biontech) Germany $687M - [**Laronde**](https://millionrounds.com/company/laronde) Laronde develops an eRNA-based therapeutic platform that is capable of indicating diverse proteins inside the body. United States $440M - [*CT* **City Therapeutics**](https://millionrounds.com/company/city-therapeutics) United States $235M - [**Matchpoint Therapeutics**](https://millionrounds.com/company/matchpoint-therapeutics) Matchpoint Therapeutics is a biotechnology company based in Cambridge, Massachusetts, founded in 2021. United States $220M - [**Osanni Bio**](https://millionrounds.com/company/osanni-bio) Osanni Bio is a biotechnology company developing therapies aimed at preventing and reversing blindness caused by retinal diseases. United States $190M - [**Repertoire Immune Medicines**](https://millionrounds.com/company/repertoire-immune-medicines) Repertoire Immune Medicines is a clinical stage biotechnology company. - $189M - [**Septerna**](https://millionrounds.com/company/septerna) Septerna is a biotech firm unlocking diverse drug discovery potential in G protein-coupled receptors across various diseases. United States $150M - [**MOMA Therapeutics**](https://millionrounds.com/company/moma-therapeutics) MOMA Therapeutics is a clinical-stage biotechnology company based in Cambridge, Massachusetts, founded in 2020. United States $150M ### Series A 10 startups · $1.7B raised - [**Erasca**](https://millionrounds.com/company/erasca) Erasca is a developer of oncology drugs intended to provide precision oncology options. United States $739M - [**Morphic Therapeutic**](https://millionrounds.com/company/morphic-therapeutic) Morphic Therapeutic is a biotechnology company that develops oral integrin therapies to treat serious chronic diseases. United States $328M - [**Averna Therapeutics**](https://millionrounds.com/company/averna-therapeutics) Averna Therapeutics develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA. United States $170M - [**Ottimo Pharma**](https://millionrounds.com/company/ottimo-pharma) Ottimo Pharma is a private, clinical-stage biotechnology company based in Sandwich, Kent, United Kingdom. United Kingdom $140M - [**Kronos Bio**](https://millionrounds.com/company/kronos-bio) Kronos Bio focuses on the research and development of first-in-class therapies that modulate historically recalcitrant cancer. United States $123M - [**Exsilio Therapeutics**](https://millionrounds.com/company/exsilio-therapeutics) Exsilio develops genomic therapeutics that introduce therapeutic genes into safe shelters within the DNA. - $82M - [**Faze Medicines**](https://millionrounds.com/company/faze-medicines) Faze Medicines was a biotechnology company based in Cambridge, Massachusetts, founded in 2020. United States $81M - [**Triplet Therapeutics**](https://millionrounds.com/company/triplet-therapeutics) Triplet Therapeutics develops and commercializes ribonucleic acid targeted therapeutics for the treatment of Huntington's disease. United States $49M ### Series C and later 10 startups · $2.2B raised - [**Arcus Biosciences**](https://millionrounds.com/company/arcus-biosciences) Arcus Biosciences is a biopharmaceutical company that discovers, develops, and commercializes novel therapies for the treatment of cancer. United States $427M - [**Encoded Therapeutics**](https://millionrounds.com/company/encoded-therapeutics) Encoded Therapeutics is a Harnessing the regulatory genome to create next-generation molecular therapies. United States $379M - [**Solid Biosciences**](https://millionrounds.com/company/solid-biosciences) Solid Biosciences is a life science company that conducts research for the treatment of Duchenne muscular dystrophy. United States $333M - [**Metacrine**](https://millionrounds.com/company/metacrine) Metacrine is a clinical-stage bio pharmaceutical company focused on building an innovative pipeline of best-in-class drugs. United States $173M - [**Rani Therapeutics**](https://millionrounds.com/company/rani-therapeutics) Rani is a clinical-stage biotherapeutics company that enables the development of orally administered biologics to improve patient outcomes. United States $168M - [**Hemab**](https://millionrounds.com/company/hemab) Hemab is a clinical-stage biotech company developing prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders. Denmark $157M - [**KSQ Therapeutics**](https://millionrounds.com/company/ksq-therapeutics) KSQ Therapeutics is using CRISPR technology within a powerful drug discovery engine to enable high-confidence drug development. United States $156M - [**Lyndra Therapeutics**](https://millionrounds.com/company/lyndra-therapeutics) Lyndra Therapeutics is a clinical-stage biopharmaceutical company based in Watertown, Massachusetts. United States $156M **How this map is made.** Every startup here works in Biotech and has raised money in a round we track that names Invus as an investor. Each sits under the stage of its latest round. Rebuilt nightly; updated 15 November 2026. ## More portfolio maps [All portfolios](https://millionrounds.com/portfolio-maps) [Portfolio map **Invus portfolio map** 69 startups · $18B](https://millionrounds.com/portfolio-maps/invus-portfolio-map)[Co-investors **Who invests with Invus** 65 co-investors](https://millionrounds.com/portfolio-maps/invus-co-investors)[Sector portfolio **RA Capital Management's Biotech portfolio** 197 startups · $38B](https://millionrounds.com/portfolio-maps/ra-capital-management-biotech-portfolio)[Sector portfolio **OrbiMed's Biotech portfolio** 176 startups · $28B](https://millionrounds.com/portfolio-maps/orbimed-biotech-portfolio)[Sector portfolio **Pioneer Fund's AI portfolio** 171 startups · $2.8B](https://millionrounds.com/portfolio-maps/pioneer-fund-2-ai-portfolio)[Sector portfolio **Gaingels' AI portfolio** 146 startups · $14B](https://millionrounds.com/portfolio-maps/gaingels-ai-portfolio) ## Raising from investors like Invus? Find the investors who back startups like yours, with their cheques, rounds and partners, in the app with filters, lists and exports. [Find investors](https://millionrounds.com/login?join=1&next=/app/investors)[Market maps](https://millionrounds.com/market-maps)